European project opens way for better understanding of human diseases
In the edition of Nature dated Thursday 21 February 2002, an international team of scientists report their analysis of the genome of fission yeast (Schizosaccharomyces pombe). The project, largely funded through a €6.9 million from the European Commission, is likely to have major implications for the future of cancer and other bio-medical research. Fifty of the yeast genes were found to have significant similarity with genes involved in human diseases, including cystic fibrosis, hereditary deafness and non insulin dependent diabetes, and half were found to be cancer related. Because yeast cells are similar to human cells but easier to study, this work is leading to a better understanding of what each gene controls, and how they may be involved in cancer and other diseases in humans.
Research Commissioner Philippe Busquin commented this scientific breakthrough saying: "This type of research is yet another example for the strong link between scientic advancement and practical use for the citizen. Unlike other genomics projects, Europe has taken the leading role in this research through networking of the best. That is precisely what I have been advocating since the Lisbon summit in spring 2000, where I proposed to create a European Research Area."
Schizosaccharomyces pombe is known as fission yeast because it reproduces by splitting rather than by budding like Saccharomyces cerevisiae (baker`s yeast), and is occasionally used for brewing beer. Like man, it is an eukaryote, i.e. an organism that, unlike bacteria, contains its genome in a nucleus inside the cell and is generally thought to be more complex.
The completion of the sequence and analysis of this genome is the result of the joint effort of 13 European laboratories led by the Wellcome Trust Sanger Institute which sequenced two-thirds of the genome and did the gene predictions and annotation for all of the sequence. The global analysis of the genome was performed jointly by Cancer Research UK and the Sanger Institute. The second phase of the sequencing was carried out by a European Consortium led by the Sanger Institute. The consortium consisted of major European laboratories that also contributed to the S. cerevisiae genome project. The majority of funding for the project was from the European Commission (€6.9 million out of a total budget of €9.4 million).
The 133 authors of the Nature paper include Dr Paul Nurse of Cancer Research UK, whose work on fission yeast and cell division recently led to the award for the Nobel prize for Medicine, and Dr Bart Barrell and Val Wood from the Wellcome Trust Sanger Institute near Cambridge.
Dr Nurse stated: `Biomedicine depends on our study of model organisms, which can provide key insights into the way in which the more complex human genome works. The genome fission yeast is only the sixth higher (eukaryotic) life form to be decoded. Significantly, many decisions the humble yeast cell makes in cell division use genes that are closely related to genes implicated in many human cancers: this small organism could prove vital in helping to better understand and treat cancer and other diseases.`
Val Wood, from the Wellcome Trust Sanger Institute, commented: `Each step in our study of genomes brings new and surprising understanding of the common basis that underlies the way cells work. In this international collaboration we have provided high-quality sequence and precise analysis of the genes buried in the fission yeast genetic code, demonstrating the value of sharing genomic information. Through this shared effort, the genome of S. pombe is one of the best annotated of any non-bacterial cell. As well as finding cancer-related genes, we have begun to illustrate how other functions in this, perhaps the simplest complex cell, can bring new tools to understanding ourselves and our place in evolution.`
The joint effort to sequence and analyse the sequence of a micro-organism to better understand and improve human health is a typical an example of the continuing European effort in the area of Genomics and Biotechnology for Health. Building on such major achievements, the European Commission proposes to allocate €2.2 billion to this priority in the forthcoming Sixth Framework Programme (2002-2006).
Stéphane Hogan | alphagalileo
The most recent press releases about innovation >>>
Die letzten 5 Focus-News des innovations-reports im Überblick:
Physicists of the University of Würzburg have made an astonishing discovery in a specific type of topological insulators. The effect is due to the structure of the materials used. The researchers have now published their work in the journal Science.
Topological insulators are currently the hot topic in physics according to the newspaper Neue Zürcher Zeitung. Only a few weeks ago, their importance was...
In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.
Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...
Mapping the interaction of a single atom with a single photon may inform design of quantum devices
Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...
A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.
Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...
In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.
“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...